Expression profiling in multistage hepatocarcinogenesis: Identification of HSP70 as a molecular marker of early hepatocellular carcinoma

Hepatology

Volumn 37, Issue 1, 2003, Pages 198-207

  Chuma, Makoto ^a,b   Sakamoto, Michiie ^a   Yamazaki, Ken ^a   Ohta, Tsutomu ^a   Ohki, Misao ^a   Asaka, Masahiro ^b   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEAT SHOCK PROTEIN 70;

ACUTE DISEASE; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE MARKER; DNA MICROARRAY; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRECANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 0037223571     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50022     Document Type: Article

References (43)

1. Okuda K. Hepatocellular carcinoma: Recent progress. Hepatology 1992; 15:948-963.
2. Arakawa M, Kage M, Sugihara S, Nakashima T, Suenaga M, Okuda K. Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Observations in five cases. Gastroenterology 1986;91:198-208.
3. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988;319:525-532.
4. Tsuda H, Hirohashi S, Shimamoto Y, Terada M, Hasegawa H. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology 1988;95:1664-1666.
5. Takayama T, Makuuchi M, Hirohashi S, Sakaomoto M, Okazaki N, Takayasu K, Kosuge T, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990;336:1150-1153.
6. Sakamoto M, Hirohashi S, Shimamoto Y. Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991;22:172-178.
7. Hirohashi S, Ishak KG, Kojiro M, Wanless IR, Theise ND, Tsukuma H, Blum HE, et al. Hepatocellular carcinoma. In: Hamilton SR and LA Aaltonen, eds. Pathology and Genetics of Tumors of the Digestive System. Lyon: IARC Press, 2000:159-172.
8. Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Takashima T, Nakanuma Y, Unoura M, et al. Benign and malignant nodules in cirrhotic livers: Distinction Based on Blood Supply. Radiology 1991;178:493-497.
9. Kudo M. Morphological diagnosis of hepatocellular carcinoma: Special emphasis on intranodular hemodynamic imaging. Hepatogastroenterology 1998;45:1226-1231.
10. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, Kondo H, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995;75:2844-2852.
11. Sclemper RJ, Itabashi M, Kato Y, Lewin KJ, Riddell RH, Shimoda T, Sipponen P, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 1997;349:1725-1729.
12. Sclemper RJ, Itabashi M, Kato Y, Lewin KJ, Riddell RH, Shimoda T, Sipponen P, et al. Differences in diagnostic criteria for used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer 1998; 82:60-69.
13. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-470.
14. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee, MS, Mittmann M, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996;14:1675-1680.
15. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.
16. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999;286:531-537.
17. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000;406:536-540.
18. Ishak KG, Anthony PP, Sobin LH. Histological Typing of Tumors of the Liver. New York: WHO, Springer-Verlag, 1994.
19. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-14868.
20. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-994.
21. Kanai Y, Ushijima S, Nakanishi Y, Hirohashi S. Reduced mRNA expression of the DNA demethylase, MBD2, in human colorectal and stomach cancers. Biochem Biophys Res Commun 1999;264:962-966.
22. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29: 577-580.
23. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536.
24. Bukau B, HorwichAL. The HSP70 and HSP60 chaperone machines. Cell 1998;92:351-366.
25. Kawanishi K, Shinozaki H, Doki Y, Sakita I, Inoue M, Yano M, Tsujinaka T, et al. Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer 1999;85:1649-1657.
26. Maehara Y, Oki E, Abe T, Tokunaga E, Shibahara K, Kakeji Y, Sugimachi K. Overexpression of the heat shock protein HSP70 family and p53 protein and prognosis for patients with gastric cancer. Oncology 2000;58: 144-151.
27. Lazaris AC, Theodoropoulos GE, Davaris PS, Panoussopoulos D, Nakopoulou L, Kittas C, Golematis BC. Heat shock protein 70 and HLA-DR molecules tissue expression. Prognostic implications in colorectal cancer. Dis Colon Rectum 1995;38:739-745.
28. Gress TM, Muller-Pillasch F, Weber C, Lerch MM, Friess H, Buchler M, Beget HG, et al. Differential expression of heat shock proteins in pancreatic carcinoma. Cancer Res 1994;54:547-551.
29. Rahlan R, Kaur J. Differential expression of Mr 70,000 Heat shock protein in normal, premalignant, and malignant human uterine cervix. Clin Cancer Res 1995;1:1217-1222.
30. Kingston RE, Baldwin AS, Sharp PA. Regulation of heat shock protein 70 gene expression by c-myc. Nature 1984;312:280-282.
31. Konno A, Sato N, Yagihashi A, Torigoe T, Cho J, Torimoto K, Hara I, et al. Heat or stress-inducible transformation-associated cell-stress antigen on the activated H-ras-oncogene-transfected rat fibroblast. Cancer Res 1989; 49:6578-6582.
32. Pinashi-Kimmhi O, Michalowitz D, Ben-Zeev A, Oren M. Specific interaction between the p53 cellular tumor antigen and major heat shock proteins. Nature 1986;320:182-185.
33. Desiderio MA, Tacchini L, Anzon E, Pogliaghi G, Radice L, Bernelli-Zazzera A. Effect of polyamine imbalance on the induction of stress genes in hepatocarcinoma cells exposed to heat shock. Hepatology 1996;24: 150-156.
34. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 2002;62:3939-3944.
35. Yin Y, Qin Q, Zhang W, Zhao J, Zhang C, Yu J. Overexpression of heat shock protein 70 and spontaneous cancer cell apoptosis in hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 2001;9:84-85.
36. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cdna microarray: Identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001;61:2129-2137.
37. Bern WT, Thomas GE, Mamone JY, Homan SM, Levy BK, Johnson FE, Coscia CJ. Overexpression of sigma receptors in nonneural human tumors. Cancer Res 1991;24:6558-6562.
38. Degen WG, Weterman MA, van Groningen JJ, Cornelissen IM, Lemmers JP, Agterbos MA, Geurts van Kessel A, et al. Expression of nma, a novel gene, inversely correlates with the metastatic potential of human melanoma cell lines and xenografts. Int J Cancer 1996;65:460-465.
39. Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, Ryu B, et al. Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res 2001;61:4320-4324.
40. Liau LM, Lallone RL, Seitz RS, Buznikov A, Gregg JP, Kornblum HI, Nelson SF, et al. Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. Cancer Res 2000;60:1353-1360.
41. Koide N, Hada H, Shinji T, Ujike K, Hirasaki S, Yumoto Y, Hanafusa T, et al. Expression of the midkine gene in human hepatocellular carcinoma. Hepatogastroenterology 1999;46:3189-3196.
42. Grigioni WF, Garbisa S, D'Errico A, Baccarini P, Stetler-Stevenson WG, Liorta LA, Mancini AM. Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens. Am J Pathol 1991;138:647-654.
43. Shima F, Okada T, Kido M, Sen H, Tanaka Y, Tamada M, Hu CD, et al. Association of yeast adenylyl cyclase with cyclase-associated protein CAP forms a second Ras-binding site which mediates its Ras-dependent activation. Mol Cell Biol 2000;20:26-33.